PLAY PODCASTS
#338: Pfizer Study Docs Exposed – Pharma Exec Sasha Latypova Speaks Out
Episode 338

#338: Pfizer Study Docs Exposed – Pharma Exec Sasha Latypova Speaks Out

Former pharma executive Sasha Latypova reveals shocking findings from Pfizer’s newly released Covid-19 vaccine trial documents, questioning the adequacy of safety testing and regulatory claims. We break down what the data shows—and what it means for public health.

BS Free MD with Drs. May and Tim Hindmarsh - Medicine, Life, Family, Physician, Doctor, Healthcare, Medical History · Doctor Podcast Network, Drs May and Tim Hindmarsh

February 13, 20251h 19m

Audio is streamed directly from the publisher (chrt.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Buckle up—this episode is coming in hot! As Pfizer continues its slow release of Covid-19 mRNA vaccine study data, we dig into what’s been uncovered so far.

Today’s guest, Sasha Latypova, a former pharmaceutical industry executive with over 20 years in clinical research and regulatory affairs, shares her findings from the first 400 pages released through a FOIA request. Her analysis raises serious concerns, including whether Pfizer ever conducted proper safety testing and the CDC/FDA’s claims that the vaccine “stays in the injection site.” Spoiler: The data suggests otherwise.
 

We’re linking the full Pfizer documents on our website so you can see the data for yourself!

🚨 Links & Resources:
📄 Pfizer Safety Testing PDF: Link Here
📢 Judicial Watch & Pfizer Report: Read More
🎥 Event: Pharma Exposed (May 24, 2022) Watch Here

 

🔍 Our Advice & Disclaimer:
This podcast is for educational purposes only and does not constitute medical advice. The views expressed are solely those of the hosts and guest, and do not reflect those of any affiliated organizations.

 

💬 Stay Connected!
📸 Instagram: @bsfreemd
👍 Facebook: BS Free MD
🌐 Website: bsfreemd.com

Have questions? Email us at [email protected]. Thanks for tuning in—you’re the reason we do this!

Topics

foia releasepfizer documentspharmaceutical industrycovid-19 vaccinecdc fda controversymrna safetyvaccine trialssasha latypova